Lucid Diagnostics Inc. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Lucid Diagnostics Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2024-12-31 was $9.18M.
- Lucid Diagnostics Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2024-09-30 was $1.76M, a 959.04% increase year-over-year.
- Lucid Diagnostics Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2024-06-30 was $1.85M.
- Lucid Diagnostics Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2024-03-31 was $688.00K.
- Lucid Diagnostics Inc. stock issued during period, value, conversion of convertible securities for fiscal 2024 was $13.48M, a 8021.69% increase from fiscal 2023.
- Lucid Diagnostics Inc. stock issued during period, value, conversion of convertible securities for fiscal 2023 was $166.00K.
- Lucid Diagnostics Inc. stock issued during period, value, conversion of convertible securities for fiscal 2021 was $22.40M.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2024-12-31 | $9.18M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $13.48M 10-K · filed 2025-03-24 |
| 2024-09-30 | $1.76M 10-Q · filed 2025-11-12 | $4.30M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $1.85M 10-Q · filed 2025-08-12 | $2.71M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $688.00K 10-Q · filed 2025-05-13 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $166.00K 10-K · filed 2025-03-24 |
| 2023-09-30 | $166.00K 10-Q · filed 2024-11-12 | |
| 2021-12-31 | $22.40M 10-K · filed 2023-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |